A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 Possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL)

Blood

Volumn 104, Issue 8, 2004, Pages 2444-2451

  Charrin, Christiane ^a   Thomas, Xavier ^b   Ffrench, Martine ^b   Le, Quoc Hung ^b   Andrieux, Joris ^b   Mozziconacci, Marie Joelle ^b   Laï, Jean Luc ^b   Bilhou Nabera, Chrystele ^b   Michaux, Lucienne ^b   Bernheim, Alain ^b   Bastard, Christian ^b   Mossafa, Hossein ^b   Perot, Christine ^b   Maarek, Odile ^b   Boucheix, Claude ^b   Lheritier, Véronique ^b   Delannoy, André ^b   Fière, Denis ^b   Dastugue, Nicole ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; MERCAPTOPURINE; MITOXANTRONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ANEUPLOIDY; ARTICLE; BLOOD CELL COUNT; CANCER SURVIVAL; CHROMOSOME; CHROMOSOME 13; CHROMOSOME 15; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME 3; CHROMOSOME 4; CHROMOSOME 7; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; DIPLOIDY; DNA CONTENT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPODIPLOID; LEUKEMIA REMISSION; LEUKOCYTOSIS; MAINTENANCE THERAPY; MALE; PHENOTYPE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TETRASOMY; TRIPLOIDY;

EID: 4944256625     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-04-1299     Document Type: Article

References (34)

1. Secker-Walker LM, Lawler SD, Hardisty RM. Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis. BMJ. 1978;2:1529-1530.
2. Third International Workshop on Chromosomes in Leukemia: Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Cancer Res. 1983;43:868-873.
3. Bloomfield CD, Goldman AI, Alimena G, et al. Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood. 1986;67:415-420.
4. Secker-Walker LM, Chessells JM, Stewart EL, Swansbury GJ, Richards S, Lawler SD. Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long-term follow-up. Br J Haemat. 1989;72:336-342.
5. Pui CH, Crist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood. 1990; 76:1449-1463.
6. Faderl S, Kantarjian HM, Talpaz M, Estrov Z. Clinical significance of cytogenetic abnormalities in adult lymphoblastic leukemia. Blood. 1998;91: 3995-4019.
7. Williams DL, Tsiatis A, Brodeur GM, et al. Prognostic importance of chromosome number in 136 untreated chidren with acute lymphoblastic leukemia. Blood. 1982;60:864-871.
8. Look AT, Roberson PK, Williams DL, et al. Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood. 1985;65:1079-1086.
9. Trueworthy R, Shuster J, Look T, et al. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group Study. J Clin Oncol. 1992;10:606-613.
10. Pui CH, Williams DL, Raimondi SC, et al. Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia. Blood. 1987;70:247-253.
11. Heerema NA, Nachman JB, Sather HN, et al. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood. 1999;94:4036-4046.
12. Pui CH, Carroll AJ, Head D, et al. Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood. Blood. 1990;76:590-596.
13. Groupe Français de Cytogénétique Hématologique. Cytogenetic abnormalities in adult lymphoblastic leukemia: correlations with hématologic findings and outcome. A collaborative study of the Groupe Français de Cytogénétique Hématologique. Blood. 1996;87:3135-3142.
14. Secker-Walker LM, Prentice HG, Durrant J, Richards S, Hall E, Harrisson G. Cytogenetic adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party. Br J Haematol. 1997;96:601-610.
15. Wetzler M, Dodge RK, Mrozek K, et al. Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. Blood. 1999;93:3983-3993.
16. Callen DF, Raphael K, Michael PM, Garson OM. Acute lymphoblastic leukemia with a hypodiploid karyotype with less than 40 chromosomes: the basis for division into two subgroups. Leukemia 1989;3:749-752.
17. Thomas X, Boiron JM, Huguet F, et al. Intensive therapy in 922 adults patients with acute lymphoblastic leukemia (ALL): analysis of the French-Belgian-Swiss-Australian LALA-94 trial [abstract]. Blood. 2002;584:156a.
18. Delannoy A, Cazin B, Thomas X, et al. Treatment of acute lymphoblastic leukemia in the elderly: an evaluation of interferon alpha given as a single agent after complete remission. Leuk Lymphoma. 2002;43:75-81.
19. Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9:1783-1786.
20. Mitelman F, ed. ISCN: An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: Karger; 1995.
21. Ffrench M, Morel F, Souchier C, Benchaib M, Catallo R, Bryon PA. Choice of fixation and denaturation for the triple labelling of intra-cytoplasmic antigen, bromodeoxyuridine and DNA. Application to bone marrow plasma cells. Histochemistry. 1994;101:385-390.
22. Hoelzer D, Thiel E, Loffler H, et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood. 1988;71: 123-131.
23. Tenenhaus M, Young FW. An analysis and synthesis of multiple correspondence analysis, optimal scaling, dual scaling, homogeneity analysis and other methods for quantifying categorical multivariate data. Psychometrika. 1985;50:91-119.
24. Kantarjian HM, Walters RS, Keating MJ, et al. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J Clin Oncol. 1990;8:994-1004.
25. Westbrook CA, Hooberman AL, Spino C, et al. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study. Blood. 1992;80: 2983-2990.
26. Greenwood M. The natural duration of cancer. In: Reports on Public Health and Medical Subjects. Vol.33. London, United Kingdom: H. M. Stationery Office; 1926:1-26.
27. Pui CH, Carroll AJ, Raimondi SC, et al. Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid less than 45 line. Blood. 1990;75:1170-1177.
28. Onodera N, McCabe NR, Nachman JB, et al. Hyperdiploidy arising from near-haploidy in childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer. 1992;4:331-336.
29. Onodera N, McCabe NR, Rubin CM. Formation of a hyperdiploid karyotype in childhood acute lymphoblastic leukemia. Blood. 1992;80:203-208.
30. Ma SK, Chan GC, Wan TS, et al. Near-haploid common acute lymphoblastic leukaemia of childhood with a second hyperdiploid line: a DNA ploidy and fluorescence in-situ hybridization study. Br J Haemat. 1998;103:750-755.
31. Stark B, Jeison M, Gobuzov R, et al. Near haploid childhood acute lymphoblastic leukemia masked by hyperdiploid line: detection by fluorescence in situ hybridization. Cancer Genet Cytogenet. 2001;128:108-113.
32. Gibbons B, MacCallum P, Watts E, et al. Near haploid acute lymphoblastic leukemia: seven new cases and a review of the literature. Leukemia. 1991;5:738-743.
33. Sandberg AA, Wake N, Kohno S. Chromosomes and causation of human cancer and leukemia, XLVII: severe hypodiploidy and chromosome conglomerations in ALL. Cancer Genet Cytogenet. 1982;5:293-307.
34. Oshimura M, Freeman AI, Sandberg AA. Chromosomes and causation of human cancer and leukemia, XXIII: near-haploidy in acute leukemia. Cancer. 1977;40:1143-1148.